Fastpack Vitamin D and 1 more
System, Test, Vitamin D. 510(k) K123983, from Qualigen, Inc. (Carlsbad, CA). Product code MRG, class 2.
As of Nov 21, 2026, K123983 is an FDA 510(k) held by Qualigen, Inc., substantially equivalent on Jul 3, 2013 after 189 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 189 days
- Recalls: 2
FastPack® Vitamin D Immunoassay is intended for the quantitative determination of total 25-hydroxyvitamin D and other hydroxylated metabolites in human serum and plasma. The assay is to be used as an aid in the assessment of vitamin D sufficiency in adults. The FastPack® Vitamin D Immunoassay is intended for use with the FastPack® Analyzer.
- Liaison 25 Oh Vitamin D Total AssayK112725 · DiaSorin, Inc. · Jan 20, 2012
| Jul 7, 2017 | Z-3112-2017Specific lots have been reported to produce falsely lower than expected results for Vitamin D | Terminated |
| Nov 8, 2013 | Z-0550-2014Qualigen initiated this recall because the FastPack kit may cause lower than expected results due to a manufacturing defect. | Terminated |
- Atellica IM Vitamin D Total II (VitDII)K260674 · Siemens Healthcare Diagnostics, Inc. · Nov 6, 2026
- MAGLUMI 25-OH Vitamin D, MAGLUMI X3 Fully-auto chemiluminescence immunoassay analyzerK232587 · Shenzhen New Industries Biomedical Engineering Co., Ltd. · Apr 12, 2024
- ALFIS Vitamin D, ALFIS-3 AnalyzerK221817 · Immunostics Inc., · Sep 22, 2023
- Access 25(OH) Vitamin D TotalK223503 · Beckman Coulter, Inc. · Jan 19, 2023
- Elecsys Vitamin D total IIIK210901 · Roche Diagnostics · Sep 1, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 26, 2012
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1825
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files